Hydroxychloroquine Drug Market to Witness Growth Acceleration by 2028

 

The global hydroxychloroquine drug market is anticipated to grow at a significant CAGR of 5.7% during the forecast period. An increasing number of malaria cases leading to the production of more medicine across the globe is acting as an important factor driving the growth of the market. For instance, as per the information provided by World Health Organization (WHO) in 2020, there were an estimated 241 million cases of malaria globally and among which the estimated number of malaria deaths account for around 627000 in 2020. So, the utilizing of hydroxychloroquine drugs in the form of tablets and vials supports in reducing the death rate.

To Request a Sample of our Report on Global Hydroxychloroquine Drug Market:  https://www.omrglobal.com/request-sample/hydroxychloroquine-drug-market-size

Moreover, the growing demand for novel hydroxychloroquine and the rising penetration of generic drugs are also contributing significantly towards the growth of the market. However, the market growth for hydroxychloroquine is anticipated to be hampered by the ambiguity of long-term consequences along with other side effects including cardiac problems, diarrhea, and stomach aches that could be observed in the patients. Additionally, FDA had cautioned against the use of hydroxychloroquine for COVID-19 outside of the hospital setting or a clinical trial due to the risk of heart rhythm problems.

A full Report of Global Hydroxychloroquine Drug Market is Available @  https://www.omrglobal.com/industry-reports/hydroxychloroquine-drug-market-size

Global Hydroxychloroquine Market Segmentation

By Application

  • COVID-19
  • Malaria
  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Others (Porphyria cutanea tarda (PCT) and Q Fever)

By Dosage Type

  • 100 mg
  • 200 mg
  • 400 mg
  • 600 mg
  • 800 mg

Regional Analysis

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

Company Profiles 

  • Abbott Healthcare Pvt. Ltd
  • Advanz Pharma Corp.
  • Agio Pharmaceuticals Ltd.
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Bayer AG
  • Bristol Laboratories Ltd.
  • Cadila Healthcare Ltd. (CHL)
  • Cardinal Health, Inc.
  • Chemo Biological Ltd.
  • Covis Pharmaceuticals, Inc.
  • Reddy’s Laboratories Ltd.
  • Fdc Ltd.
  • Intas Pharmaceuticals Ltd.
  • Kopran Ltd.
  • Laurus Labs Ltd.
  • Lupin Ltd.
  • Mangalam Drugs and Organics Ltd.
  • Mylan N.V.
  • Shenhua Pharmaceutical Co., Ltd.
  • Snehal Pharma & Surgical Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Wallace Pharmaceuticals Ltd.
  • Zaneka Healthcare Pvt. Ltd.

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hydroxychloroquine-drug-market-size

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404